Covid-19-induced hyperleucocytosis in chronic lymphocytic leukaemia

Balraj Singh, Sarah Ayad, Parminder Kaur, Ro Jay Reid, Sachin Gupta, Michael Maroules

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19). COVID-19 usually presents with respiratory symptoms but can affect multiple organ systems. A wide spectrum of complications can occur depending upon the comorbidities of patients. There is limited literature available regarding the presentation and outcome of COVID-19 in chronic lymphocytic leukaemia (CLL) patients. We report 2 cases of COVID-19-induced hyperleucocytosis (WBC count >100,000/μl) in CLL patients.

Original languageEnglish (US)
JournalEuropean Journal of Case Reports in Internal Medicine
Volume8
Issue number3
DOIs
StatePublished - 2021

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this